作者:
关键词
Acarbose (PubChem CID: 444254)Anti-hyperglycaemic drugsCanagliflozin (PubChem CID: 24812758)Dapagliflozin (PubChem CID: 9887712)Diabetes mellitusEmpagliflozin (PubChem CID: 11949646)Exenatide (PubChem CID: 45588096)Immunosuppressant drugsLifestyle interventionLinagliptin (PubChem CID: 10096344)Liraglutide (PubChem CID: 16134956)Liver transplantationMetformin (PubChem CID: 4091)Pioglitazone (PubChem CID: 4829)Sitagliptin (PubChem CID: 4369359)
主题词
糖尿病并发症(Diabetes Complications);糖尿病(Diabetes Mellitus);膳食疗法(Diet Therapy);疾病管理(Disease Management);运动疗法(Exercise Therapy);人类(Humans);降血糖药(Hypoglycemic Agents);免疫抑制剂(Immunosuppressive Agents);生活方式(Life Style);肝硬化(Liver Cirrhosis);肝移植(Liver Transplantation)
DOI
10.1016/j.phrs.2019.01.042
PMID
30690071
发布时间
2019-08-23
- 浏览28
Pharmacological research
556-573页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文